Abstract

A method for the determination of the neuractive compound N- n-propylmorapomorphine (NPA) in biological tissues is described. Isolation of NPA from serum or brain tissue was achieved via liquid-liquid extraction from phosphate-buffered tissue extract (0.25 M, pH 7.2) into ethyl acetate. The NPA, along with a [ 2H 7]NPA analogue serving as internal standard, was converted to the corresponding bis(trifluoroacetyl) ester by treatment with excess trifluoroacetic anhydride at 75°C. The electrophoric derivatives were analyzed by fused-silica capillary gas chromatography-mass spectrometry in the negative ion chemical ionization mode. Selected ion monitoring of the [M − CF 3CO] − ions of derivatized NPA ( m/z 390) and internal standard [ 2H 7]NPA ( m/z 397) permitted the quantitation of NPA in serum and brain samples obtained from rats treated with either free NPA or the prodrug methylenedioxy-NPA (MDO-NPA). Calibration was conducted down to a practical limit of assay sensitivity, at 0.50 ng NPA per ml of serum and 0.50 ng NPA per g of brain. The relative standard deviation for replicate serum samples spiked at 20 ng/ml was 4.2% ( n = 5) and for brain samples at 10 ng/g, it was 3.6%. This method revealed differences in the free NPA brain/serum ratios in rats treated separately with the stereoisomers R-(−)-MDO-NPA and S-(+)-MDO-NPA.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.